Phase Iii Multicenter Randomized Study Of Concurrent Twice-A-Day Radiotherapy With And Without Cisplatin-5fu (Bircf) In Unresectable Pharyngeal Carcinoma. Results At 18 Months (Fnclcc-Gortec).
JOURNAL OF CLINICAL ONCOLOGY(2004)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要